These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12954709)

  • 21. RhD negative women. Are we ready to change practice?
    Wray J
    Pract Midwife; 2000 Oct; 3(9):26-8. PubMed ID: 12026547
    [No Abstract]   [Full Text] [Related]  

  • 22. [Is it always necessary to give anti-D gamma-globulins in the case of spontaneous miscarriage in Rhesus-negative patients?].
    Salvat J; Slamani L; Capilna M; Brescu O
    Contracept Fertil Sex; 1997 Apr; 25(4):V-IX. PubMed ID: 9229512
    [No Abstract]   [Full Text] [Related]  

  • 23. Cochrane made simple. Anti-D administration during pregnancy for preventing Rhesus isoimmunisation.
    Anderson T
    Pract Midwife; 1999 Jun; 2(6):10. PubMed ID: 10481667
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-D. Part 2: Risks and benefits.
    Wickham S
    Pract Midwife; 1999 Jun; 2(6):38-9. PubMed ID: 10481677
    [No Abstract]   [Full Text] [Related]  

  • 25. Preventing rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?
    Harding K
    Br J Obstet Gynaecol; 1997 Jul; 104(7):869-70. PubMed ID: 9236664
    [No Abstract]   [Full Text] [Related]  

  • 26. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists.
    Lee D; Contreras M; Robson SC; Rodeck CH; Whittle MJ
    Transfus Med; 1999 Mar; 9(1):93-7. PubMed ID: 10216910
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of neonatal alloimmune thrombocytopenia fetal maternal rhesus].
    Poissonnier MH
    J Gynecol Obstet Biol Reprod (Paris); 2007 Sep; 36 Suppl 1():S12-5. PubMed ID: 18228707
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical guidelines on anti-D prophylaxis: hasty critics?].
    Carbonne B; Marpeau L; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):526-8. PubMed ID: 17893030
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-D administration after childbirth for preventing Rhesus isoimmunisation.
    Anderson T
    Pract Midwife; 1999 May; 2(5):10-1. PubMed ID: 12024602
    [No Abstract]   [Full Text] [Related]  

  • 30. Authors' reply: guidance on anti-D administration in early pregnancy.
    Bolton-Maggs P; Davies T; Poles D; Cohen H
    BJOG; 2013 Dec; 120(13):1696-7. PubMed ID: 24588997
    [No Abstract]   [Full Text] [Related]  

  • 31. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 32. A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant.
    Jones ML; Wray J; Wight J; Chilcott J; Forman K; Tappenden P; Beverley C
    BJOG; 2004 Sep; 111(9):892-902. PubMed ID: 15327601
    [No Abstract]   [Full Text] [Related]  

  • 33. [Expanded rhesus prophylaxis].
    Maroni ES
    Schweiz Rundsch Med Prax; 1987 Nov; 76(45):1254-9. PubMed ID: 2827286
    [No Abstract]   [Full Text] [Related]  

  • 34. [Text of the guidelines for prevention of fetomaternal rhesus-D allo-immunization].
    College National de Gynecolegues et Obstetriciens Francais
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S131-1S135. PubMed ID: 16495839
    [No Abstract]   [Full Text] [Related]  

  • 35. Kleihauer testing. Many cases of sensitisation may be avoidable.
    Murphy WG; Ghosh S; Hughes RH; Craig JI; Greer IA
    BMJ; 1994 Sep; 309(6957):806. PubMed ID: 7848430
    [No Abstract]   [Full Text] [Related]  

  • 36. More on Rhogam.
    Keutzer B
    Midwifery Today Int Midwife; 2000; (56):68-9; author reply 69. PubMed ID: 11984911
    [No Abstract]   [Full Text] [Related]  

  • 37. Kleihauer testing. Need not be abandoned.
    Love EM; Shwe KH
    BMJ; 1994 Sep; 309(6957):805. PubMed ID: 7950581
    [No Abstract]   [Full Text] [Related]  

  • 38. Preventing RhD haemolytic disease of the newborn. Women should be counselled about source of anti-D immunoglobulin.
    Saha A
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569418
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biological markers: what changes with prophylaxis?].
    Mannessier L
    J Gynecol Obstet Biol Reprod (Paris); 2007 Sep; 36 Suppl 1():S9-11. PubMed ID: 18228706
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of post-transfusion RhD immunization using red cell exchange and intravenous anti-D immunoglobulin.
    Laspina S; O'riordan JM; Lawlor E; Murphy WG
    Vox Sang; 2005 Jul; 89(1):49-51. PubMed ID: 15938740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.